A tech­ni­cal­i­ty could keep RSV shots from kids in need

Af­ter more than five decades of try­ing, the drug in­dus­try is on the verge of pro­vid­ing ef­fec­tive im­mu­niza­tions against the res­pi­ra­to­ry syn­cy­tial virus, which has put an es­ti­mat­ed 90,000 US in­fants and small chil­dren in the hos­pi­tal since the start of Oc­to­ber.

But on­ly one of the shots is de­signed to be giv­en to ba­bies, and a glitch in con­gres­sion­al lan­guage may make it dif­fi­cult to al­low chil­dren from low-in­come fam­i­lies to get it as read­i­ly as the well-in­sured.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.